Myalgia: Clinical Trials

13 trials for Myalgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 13
Phase 33Completed 3
Phase 12Completed 2

Follow Myalgia: new trials by email Literature Review of Myalgia trials Research Report on Myalgia

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
Hesperidin, Placebo - Covid19, Anosmia
Phase 2CompletedMontreal Heart Institute2162021-02-182022-04-08
Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice
Polyherbal supplement: ReWin(d) vs Placebo - Muscle Soreness, Delayed-onset Muscle Soreness
Phase 2CompletedNatural Origins402018-10-222019-05-23
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders
Platelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections - PRP, Temporomandibular Disorder
Phase 2 / Phase 3CompletedMedical University of Silesia582017-12-072019-01-04
COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)
Comboprofen, Placebo, Ibuprofen - Delayed Onset Muscle Soreness, DOMS
Phase 2CompletedSpherium Biomed742017-07-122018-01-23
Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors
Neuromuscular taping - Breast Neoplasms
Phase 1 / Phase 2CompletedUniversity of Malaga1562016-05-012017-03-31
Phase II Study of AP0302 5% Versus a Vehicle Comparator
S-Ibuprofen Topical Gel 5%, Vehicle Topical Gel - Pain, Delayed Onset Muscle Soreness
Phase 2CompletedAponia Laboratories, Inc.1472015-01-012019-02-25
Belimumab in Idiopathic Inflammatory Myositis
Belimumab, Placebo - Myositis
Phase 2 / Phase 3CompletedNorthwell Health172015-01-012024-02-09
Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
Cunermuspir, Placebo - Neuralgia, Myalgia
Phase 1 / Phase 2CompletedMitosynergy LLC562014-01-282021-04-20
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
Vitamin D3 - Muscle Pain, Joint Pain
Phase 2CompletedHealthPartners Institute1162012-03-012019-06-18
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
PPD10558, Atorvastatin, Placebo - Myalgia, Hypercholesterolemia
Phase 2CompletedFuriex Pharmaceuticals, Inc2822011-03-012011-12-22
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Coenzyme Q10, Placebo - Pain, Weakness
Phase 2 / Phase 3CompletedCatherine Buettner682009-12-012017-01-23
Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness
Diractin - Muscle Soreness
Phase 2CompletedIDEA AG1682007-10-012009-03-20
Neurotropin Treatment of Fibromyalgia
Placebo, Neurotropin - Fibromyalgia
Phase 2CompletedNational Institute of Nursing Research (NINR)562006-08-012018-06-27

Narrower conditions

Pain (4)  ·  Arthralgia (3)  ·  Motor Activity (2)  ·  Muscle Weakness (2)  ·  Abdominal Pain (1)  ·  Anosmia (1)  ·  Asthenia (1)  ·  Breast Neoplasms (1)  ·  Bruxism (1)  ·  COVID-19 (1)  ·  Carpal Tunnel Syndrome (1)  ·  Chest Pain (1)  ·  Confusion (1)  ·  Cough (1)

Broader conditions

Muscular Diseases (13)  ·  Musculoskeletal Diseases (13)  ·  Musculoskeletal Pain (13)  ·  Nervous System Diseases (13)  ·  Neurologic Manifestations (13)  ·  Neuromuscular Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)  ·  Pain (9)  ·  Joint Diseases (4)  ·  Behavior (3)  ·  Neuromuscular Manifestations (2)  ·  Pathologic Processes (2)  ·  Peripheral Nervous System Diseases (2)  ·  Skin Diseases (2)

Interventions

Ascorbic Acid (1)  ·  Atorvastatin (1)  ·  Cholecalciferol (1)  ·  Hesperidin (1)  ·  Ibuprofen (1)  ·  Magnesium (1)  ·  belimumab (1)  ·  coenzyme Q10 (1)  ·  neurotropin (1)

Sponsors

Aponia Laboratories, Inc. (1)  ·  Catherine Buettner (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  HealthPartners Institute (1)  ·  IDEA AG (1)  ·  Medical University of Silesia (1)  ·  Mitosynergy LLC (1)  ·  Montreal Heart Institute (1)  ·  National Institute of Nursing Research (NINR) (1)  ·  Natural Origins (1)  ·  Northwell Health (1)  ·  Spherium Biomed (1)  ·  University of Malaga (1)

Countries

United States (6)  ·  Spain (3)  ·  Canada (2)  ·  Germany (1)  ·  Poland (1)

Top investigators

Aleksandra Nitecka-Buchta, DMD (1)  ·  Alice C. Shapiro, PhD RD (1)  ·  Antonio I Cuesta-Vargas, PhD (1)  ·  Catherine Buettner, MD, MPH (1)  ·  Egbert Seidel, MD (1)  ·  Galina Marder, MD (1)  ·  Inmaculada Conejo-Tirado (1)  ·  Jocelyn Dupuis, MD (1)  ·  Leorey N Saligan, C.R.N.P. (1)  ·  Margarita Perez Ruiz, MD(Res) (1)  ·  Sonia Singla, DO (1)

Results publications

PMID 26868123, PMID 29890985, PMID 32848820, PMID 37326854

NIH funding

2016 (1), K23AR055664 (1)